Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delphine Verbeke

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Anesthesiology|December 13, 2023
In Vitro Model of Prepacked Carbon Dioxide Absorber Use: Development and TestingJennifer Jouwena, Delphine Verbeke, Andre M De Wolf, et al.
Hemasphere|January 25, 2020
Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic LeukemiaDelphine Verbeke, Olga Gielen, Kris Jacobs, et al.
European Journal of Immunology|July 20, 2018
Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in miceMathijs Baens, Rocco Stirparo, Youlia Lampi, et al.
Science Translational Medicine|May 31, 2019
Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibitionRoger A Habets, Charles E de Bock, Lutgarde Serneels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2020
The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic LeukemiaDelphine Verbeke, Sofie Demeyer, Cristina Prieto, et al.
Cancer Discovery|March 3, 2018
HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia DevelopmentCharles E de Bock, Sofie Demeyer, Sandrine Degryse, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Anesthesiology|December 13, 2023
In Vitro Model of Prepacked Carbon Dioxide Absorber Use: Development and TestingJennifer Jouwena, Delphine Verbeke, Andre M De Wolf, et al.
Hemasphere|January 25, 2020
Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic LeukemiaDelphine Verbeke, Olga Gielen, Kris Jacobs, et al.
European Journal of Immunology|July 20, 2018
Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in miceMathijs Baens, Rocco Stirparo, Youlia Lampi, et al.
Science Translational Medicine|May 31, 2019
Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibitionRoger A Habets, Charles E de Bock, Lutgarde Serneels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2020
The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic LeukemiaDelphine Verbeke, Sofie Demeyer, Cristina Prieto, et al.
Cancer Discovery|March 3, 2018
HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia DevelopmentCharles E de Bock, Sofie Demeyer, Sandrine Degryse, et al.
Pageof 1